APLN, apelin, 8862

N. diseases: 226; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE Area covered: This review focuses on the in vitro and in vivo metabolic effects of apelin in physiological conditions and in the context of metabolic diseases. 30570369 2019
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE Furthermore, apelin and vasopressin secretion are significantly altered in various water metabolism disorders including hyponatremia and polyuria-polydipsia syndrome. 28620355 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE A role for exercise-induced apelin in improving metabolism indicates the possibility of a new drug target for the treatment of metabolic diseases and repairing skeletal muscle damage.Muscle Nerve 56: 1155-1163, 2017. 28164323 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE Moreover, our data identified oral apelin administration as a novel potential target to treat metabolic disorders. 26565000 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE Apelin is an adipokine which plays a role in the regulation of glucose homeostasis and may contribute to the link between increased adipose tissue mass and obesity related metabolic diseases. 23429279 2013
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.060 Biomarker group BEFREE Apelin appears as a beneficial adipokine with anti-insulin resistance properties, and thus as a promising therapeutic target in metabolic disorders. 23437347 2013